AI & Machine Learning

MacPaw's Setapp moves beyond its bundle model, offering single-app sales in a strategic pivot that empowers users and courts disgruntled developers.

With a soaring stock and a breakthrough CAR-T therapy, Immix Biopharma is set to capture investor attention. What's behind the hype for its lead drug, NXC-201?

A new report reveals a chasm between executive AI ambition and employee readiness, putting billions in tech investments at risk. Here's why HR is key.

New analytics in the duPont REGISTRY Garage app bring Wall Street-style charts to car collecting, empowering owners to trade passion assets like stocks.

Daxor reports a transformative year with 45% revenue growth, a new FDA-cleared portable analyzer, and a full pivot to a high-growth medtech company.

A new AI tool clarifies accented English for listeners in real time, sparking both excitement for global business and debate over cultural identity.

An Atlanta clinic combines lasers, biologics, and AI to challenge traditional joint surgery. Can a new marketing push make it a national alternative?

Texada Software's new AI tool promises to find millions in hidden damage for equipment rental firms, but can it overcome industry skepticism and hurdles?

As Beijing weaponizes rare earths, one company is already producing the critical alloys America's military needs, sidestepping a decades-long dependency.

Recognized by The Hackett Group, Globality's agentic AI is proving its mettle by automating complex procurement and delivering massive savings for giants like BT.

ECGI Holdings is testing a platform to turn mortgages into digital tokens, a move that could disrupt the $2.2 trillion US mortgage industry. Here's how.

New platform enhancements use 'English-as-Code' to help enterprises move AI from risky pilots to reliable, auditable production systems.

A new insurer contract expands Rocket Doctor's telehealth network to millions of New Yorkers on Medicaid and Medicare, aiming to close critical care gaps.

A new partnership leverages advanced AI and metabolomics to find novel drug targets for rare metabolic disorders, offering new hope for millions worldwide.

The new president brings a deep background in sustainable tech and operational excellence, signaling a new strategic direction for the Danaher subsidiary.

An AI firm known for fighting cancer is now partnering with Unilever, signaling a new era of biologically personalized consumer products and new ethical questions.

A new partnership between Dstillery, Keynes, and The Trade Desk cuts a 48-hour workflow to 5 minutes, heralding a new era of autonomous AI in advertising.

A landmark study of 7,600 law firm websites reveals most are neurologically misaligned with people in crisis. The solution? 'Digital trauma rooms.'

A 30-year study reveals massive ice loss, with commercial satellites providing an unprecedented, all-weather view of our planet's changing climate.

Amid a strategic overhaul, Hepion Pharmaceuticals is licensing a novel RNA-based liquid biopsy, aiming to transform early liver cancer detection.